Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
22/10/2019 7:57 pm
Bloodwork question about hexarelin. Baseline, four months in, and the numbers moved in a direction I did not expect.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Curious whether the popular dose has any basis or is just the convenient one.
22/10/2019 9:15 pm
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison. Same for me with hexarelin, unfortunately.
22/10/2019 9:34 pm
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation.
22/10/2019 10:34 pm
Same here.
Not on hexarelin but the pattern is familiar.